Yahoo Web Search

  1. Medical aesthetics company Evolus Inc on Monday beat Wall Street estimates for second-quarter revenue from its newly launched rival to Allergan Plc's Botox, which has dominated the medical ...

  2. Edited Transcript of NTLA earnings conference call or presentation 1-Aug-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 06 9:43 AM

    -------------------------------------------------------------------------------- Laura Sepp-Lorenzino, Intellia Therapeutics, Inc. - Executive VP & Chief Scientific Officer [4] ------ ...

  3. Bayer Sells Animal Health Division to Elanco: Now What?

    Zacks via Yahoo FinanceAug 20 22:38 PM

    On Tuesday, Bayer BAYRY announced the sale of its animal-health division to American competitor Elanco ELAN, for a net price of $7.6 billion. Bayer will receive $5.4 billion in cash and $2.3 ...

  4. Edited Transcript of VYGR earnings conference call or presentation 9-Aug-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 12 20:07 PM

    -------------------------------------------------------------------------------- Omar Khwaja, Voyager Therapeutics, Inc. - Chief Medical Officer and Head of Research & Development [4] ...

  5. Ron Baron Comments on Adaptive Biotechnologies Corp

    GuruFocus.com via Yahoo FinanceAug 12 22:57 PM

    Adaptive Biotechnologies Corporation (NASDAQ:ADPT) uses DNA sequencing, computational biology, software and machine learning to read and interpret cells in the immune system. We view Adaptive ...

  6. FDA approves AbbVie's new rheumatoid arthritis drug

    Reuters via Yahoo FinanceAug 16 16:29 PM

    Food and Drug Administration on Friday approved AbbVie Inc's new treatment for rheumatoid arthritis, a win for the drugmaker seeking to widen its portfolio as its blockbuster flagship ...

  7. Edited Transcript of SYBX earnings conference call or presentation 8-Aug-19 9:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 15 1:03 AM

    Shegog, Synlogic, Inc. - CFO [4] ----------------------------------------

  8. Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe

    Zacks via Yahoo FinanceAug 16 13:19 PM

    The study achieved its primary endpoint for both doses of filgotinib — 100 mg and 200 mg – measured by response on the scale of American College of Rheumatology (“ACR”). The drug demonstrated ...

  9. Agios Rides High on Tibsovo Sales Amid Acute Competition

    Zacks via Yahoo FinanceAug 15 14:30 PM

    On Aug 14, we issued an updated research report on Agios Pharmaceuticals, Inc. AGIO. The company’s top line mainly consists of product revenues from the sale of its newly launched precision ...

  10. Tuesday, August 20, 2019 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features updated research reports on 16 major stocks, including ...

  1. Ad
    related to AbbVie Inc